Commodore Capital LP

Insider Reports History

Location
New York, NY
Signature
/s/ Michael Kramarz, Managing Partner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Commodore Capital LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ambrx Biopharma Inc. 10%+ Owner Ordinary Shares 35,700,000 $330,035,790 $9.24 23 Feb 2023 By Commodore Capital Master LP
Vera Therapeutics, Inc. 10%+ Owner Class A Common Stock 4,400,000 $79,200,000 $18.00 10 Jan 2024 By Commodore Capital Master LP
Enliven Therapeutics, Inc. 10%+ Owner Common stock, par value $0.001 per share 1,448,640 $21,925,166 $15.14 23 Feb 2023 By Commodore Capital Master LP
Satsuma Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 461,286 $325,668 $0.7060 14 Nov 2022 By Commodore Capital Master LP
Vistagen Therapeutics, Inc. 10%+ Owner Pre-Funded Warrants (Right to Buy) 2,788,620 04 Oct 2023 By Commodore Capital Master LP
Vistagen Therapeutics, Inc. 10%+ Owner Tranche 2 Warrants (Right to Buy) 1,690,014 04 Oct 2023 By Commodore Capital Master LP
Vistagen Therapeutics, Inc. 10%+ Owner Tranche 1 Warrants (Right to Buy) 1,394,310 04 Oct 2023 By Commodore Capital Master LP

Insider Reports Filed by Commodore Capital LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VERA Vera Therapeutics, Inc. 10 Jan 2024 1 -$18,900,000 4 10%+ Owner 12 Jan 2024, 21:55
VTGN Vistagen Therapeutics, Inc. 04 Oct 2023 3 $0 4 10%+ Owner 06 Oct 2023, 16:05
VTGN Vistagen Therapeutics, Inc. 07 Aug 2023 1 +$17,961,079 4 10%+ Owner 09 Aug 2023, 16:10
VTGN Vistagen Therapeutics, Inc. 07 Aug 2023 0 $0 3 10%+ Owner 09 Aug 2023, 16:05
VERA Vera Therapeutics, Inc. 20 Jun 2023 1 +$6,799,004 4 10%+ Owner 22 Jun 2023, 16:10
VERA Vera Therapeutics, Inc. 14 Jun 2023 0 $0 3 10%+ Owner 22 Jun 2023, 16:05
/report/000149315223006669-commodore-capital-lp-2023-02-23 Ambrx Biopharma Inc. 23 Feb 2023 0 $0 3 10%+ Owner 03 Mar 2023, 15:05
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 2 +$13,723 4 10%+ Owner 27 Feb 2023, 16:14
ELVN IMARA Inc. 21 Feb 2023 2 +$163,498 4 10%+ Owner 23 Feb 2023, 15:05
ELVN IMARA Inc. 15 Feb 2023 0 $0 3 10%+ Owner 21 Feb 2023, 15:06
/report/000149315222032622-commodore-capital-lp-2022-11-14 Satsuma Pharmaceuticals, Inc. 14 Nov 2022 1 -$2,294,500 4 10%+ Owner 16 Nov 2022, 15:05
/report/000090571821001545-commodore-capital-lp-2021-11-24 Satsuma Pharmaceuticals, Inc. 24 Nov 2021 1 +$15,837 4 10%+ Owner 29 Nov 2021, 15:30
/report/000090571821001523-commodore-capital-lp-2021-11-19 Satsuma Pharmaceuticals, Inc. 19 Nov 2021 2 +$72,329 4 10%+ Owner 23 Nov 2021, 15:30
/report/000090571821001471-commodore-capital-lp-2021-11-10 Satsuma Pharmaceuticals, Inc. 10 Nov 2021 2 +$104,332 4 10%+ Owner 12 Nov 2021, 15:31
/report/000090571821001460-commodore-capital-lp-2021-11-08 Satsuma Pharmaceuticals, Inc. 08 Nov 2021 1 +$3,354 4 10%+ Owner 10 Nov 2021, 15:30
/report/000090571821001450-commodore-capital-lp-2021-11-04 Satsuma Pharmaceuticals, Inc. 04 Nov 2021 2 +$54,642 4 10%+ Owner 08 Nov 2021, 15:33
/report/000090571821001430-commodore-capital-lp-2021-11-02 Satsuma Pharmaceuticals, Inc. 02 Nov 2021 1 +$50,083 4 10%+ Owner 04 Nov 2021, 16:31
/report/000090571821001420-commodore-capital-lp-2021-10-29 Satsuma Pharmaceuticals, Inc. 29 Oct 2021 1 +$254,957 4 10%+ Owner 02 Nov 2021, 16:30
/report/000090571821001408-commodore-capital-lp-2021-10-27 Satsuma Pharmaceuticals, Inc. 27 Oct 2021 2 +$299,422 4 10%+ Owner 29 Oct 2021, 16:30
/report/000090571821001391-commodore-capital-lp-2021-10-21 Satsuma Pharmaceuticals, Inc. 21 Oct 2021 2 +$329,442 4 10%+ Owner 25 Oct 2021, 16:31
/report/000090571821001384-commodore-capital-lp-2021-10-19 Satsuma Pharmaceuticals, Inc. 19 Oct 2021 2 +$665,237 4 10%+ Owner 21 Oct 2021, 16:30
/report/000090571821001373-commodore-capital-lp-2021-10-15 Satsuma Pharmaceuticals, Inc. 15 Oct 2021 2 +$784,845 4 10%+ Owner 19 Oct 2021, 17:13
/report/000090571821001371-commodore-capital-lp-2021-10-14 Satsuma Pharmaceuticals, Inc. 14 Oct 2021 0 $0 3 10%+ Owner 19 Oct 2021, 17:09